{
  "Record": {
    "RecordType": "CID",
    "RecordNumber": 11707110,
    "RecordTitle": "Trametinib",
    "Section": [
      {
        "TOCHeading": "Structures",
        "Description": "Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.",
        "Section": [
          {
            "TOCHeading": "2D Structure",
            "Description": "A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (HÃ¤hnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ",
            "URL": "https://doi.org/10.1186/s13321-018-0293-8",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "3D Conformer",
            "Description": "A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.",
            "URL": "https://doi.org/10.1186/1758-2946-5-1",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Description": "Trametinib",
                "Value": {
                  "Number": [
                    11707110
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical Safety",
        "Description": "Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.",
        "DisplayControls": {
          "HideThisSection": true,
          "MoveToTop": true
        },
        "Information": [
          {
            "ReferenceNumber": 38,
            "Name": "Chemical Safety",
            "Value": {
              "StringWithMarkup": [
                {
                  "String": "          ",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 1,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg",
                      "Type": "Icon",
                      "Extra": "Irritant"
                    },
                    {
                      "Start": 1,
                      "Length": 1,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg",
                      "Type": "Icon",
                      "Extra": "Health Hazard"
                    }
                  ]
                }
              ]
            }
          }
        ]
      },
      {
        "TOCHeading": "Names and Identifiers",
        "Description": "Chemical names, synonyms, identifiers, and descriptors.",
        "Section": [
          {
            "TOCHeading": "Record Description",
            "Description": "Summary Information",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 2,
                "Name": "Record Description",
                "Description": "Ontology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an antineoplastic agent, an anticoronaviral agent and a geroprotector. It is a pyridopyrimidine, an organofluorine compound, an organoiodine compound, a member of acetamides, a ring assembly, a member of cyclopropanes and an aromatic amine.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 16,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/pyridopyrimidine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-17882607"
                        },
                        {
                          "Start": 54,
                          "Length": 18,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-679"
                        },
                        {
                          "Start": 415,
                          "Length": 16,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/pyridopyrimidine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-17882607"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib dimethyl sulfoxide is a kinase inhibitor. Each 1-mg tablet contains 1.127 mg trametinib dimethyl sulfoxide equivalent to 1 mg of trametinib non-solvated parent. FDA approved on May 29, 2013.  The U.S. Food and Drug Administration approved [DB08912](Tafilnar) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).  Thyroid cancer is a disease in which cancer cells form in the tissues of the thyroid. Anaplastic thyroid cancer is a rare, aggressive type of thyroid cancer. The National Institutes of Health (NIH) estimates there will be 53,990 new cases of thyroid cancer and an estimated 2,060 deaths from the disease in the United States in 2018. Anaplastic thyroid cancer accounts for approximately 1 to 2 percent of all thyroid cancers.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib%20dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        },
                        {
                          "Start": 88,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib%20dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        },
                        {
                          "Start": 140,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 274,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Mekinist",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 284,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 23,
                "Description": "FDA Pharmacology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a Kinase Inhibitor. The mechanism of action of trametinib is as a Protein Kinase Inhibitor.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 61,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 25,
                "Description": "LiverTox Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a dual-kinase inhibitor that is used in the treatment of advanced malignant melanoma, usually in combination with darbafenib. Trametinib therapy is associated with transient elevations in serum aminotransferase and alkaline phosphatase levels during therapy, but has yet to be linked cases of clinically apparent acute liver injury.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 140,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 29,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is an orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK) 1 and 2, with potential antineoplastic activity. Upon oral administration, trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity serine/threonine and tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 115,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        },
                        {
                          "Start": 195,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 241,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        },
                        {
                          "Start": 369,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        },
                        {
                          "Start": 399,
                          "Length": 6,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/serine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-5951"
                        },
                        {
                          "Start": 406,
                          "Length": 9,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/threonine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6288"
                        },
                        {
                          "Start": 420,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6057"
                        },
                        {
                          "Start": 534,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Computed Descriptors",
            "Description": "Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.",
            "Section": [
              {
                "TOCHeading": "IUPAC Name",
                "Description": "Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.",
                "URL": "https://iupac.org/what-we-do/nomenclature/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Lexichem TK 2.7.0 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 1,
                              "Type": "Italics"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "InChI",
                "Description": "The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.",
                "URL": "https://iupac.org/who-we-are/divisions/division-details/inchi/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by InChI 1.0.6 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "InChIKey",
                "Description": "An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ",
                "URL": "https://iupac.org/who-we-are/divisions/division-details/inchi/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by InChI 1.0.6 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "LIRYPHYGHXZJBZ-UHFFFAOYSA-N"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Canonical SMILES",
                "Description": "The Simplified Molecular-Input Line-Entry System (SMILES) is a widely-used line notation for chemical structures.  PubChem computes two kinds of SMILES strings for compounds: canonical SMILES (computed from chemical structures devoid of isotopic and stereochemical information), and isomeric SMILES (computed from chemical structures containing isotopic and stereochemical information).  This section shows the canonical SMILES of the compound.",
                "URL": "https://www.daylight.com/dayhtml/doc/theory/theory.smiles.html",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by OEChem 2.3.0 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Molecular Formula",
            "Description": "A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.",
            "URL": "https://pubs.acs.org/doi/abs/10.1021/ja02046a005",
            "DisplayControls": {
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Reference": [
                  "Computed by PubChem 2.1 (PubChem release 2021.05.07)"
                ],
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "C26H23FIN5O4"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Other Identifiers",
            "Description": "Other identifiers assigned to this chemical.",
            "Section": [
              {
                "TOCHeading": "CAS",
                "Description": "A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.",
                "URL": "https://www.cas.org/support/documentation/chemical-substances/faqs",
                "Information": [
                  {
                    "ReferenceNumber": 1,
                    "URL": "https://commonchemistry.cas.org/detail?cas_rn=871700-17-3",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "871700-17-3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 3,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "871700-17-3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 7,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "871700-17-3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 9,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "871700-17-3"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 12,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "871700-17-3"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Deprecated CAS",
                "Description": "The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.",
                "Information": [
                  {
                    "ReferenceNumber": 3,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "1204531-14-5"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "European Community (EC) Number",
                "Description": "The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).",
                "URL": "https://echa.europa.eu/information-on-chemicals/ec-inventory",
                "Information": [
                  {
                    "ReferenceNumber": 12,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "629-899-3"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "UNII",
                "Description": "UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).",
                "URL": "https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system",
                "Information": [
                  {
                    "ReferenceNumber": 24,
                    "Name": "UNII",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "33E86K87QN"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "DSSTox Substance ID",
                "Description": "Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.",
                "URL": "https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database",
                "Information": [
                  {
                    "ReferenceNumber": 9,
                    "URL": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID901007381",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "DTXSID901007381"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Wikidata",
                "Description": "Wikidata entity identifier for the given compound.",
                "URL": "https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662",
                "Information": [
                  {
                    "ReferenceNumber": 37,
                    "URL": "https://www.wikidata.org/wiki/Q7833138",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Q7833138"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "NCI Thesaurus Code",
                "Description": "Stable, unique code for biomedical concept",
                "URL": "https://ncithesaurus.nci.nih.gov",
                "Information": [
                  {
                    "ReferenceNumber": 29,
                    "URL": "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C77908",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "C77908"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "RXCUI",
                "Description": "RxNorm concept unique identifier (RXCUI)",
                "URL": "https://www.nlm.nih.gov/research/umls/rxnorm/index.html",
                "Information": [
                  {
                    "ReferenceNumber": 31,
                    "URL": "https://rxnav.nlm.nih.gov/id/rxnorm/1425099",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "1425099"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Synonyms",
            "Description": "Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.",
            "Section": [
              {
                "TOCHeading": "MeSH Entry Terms",
                "Description": "Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.",
                "URL": "http://doi.org/10.1186/s13321-016-0142-6",
                "DisplayControls": {
                  "ListType": "Columns"
                },
                "Information": [
                  {
                    "ReferenceNumber": 39,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "GSK 1120212"
                        },
                        {
                          "String": "GSK-1120212"
                        },
                        {
                          "String": "GSK1120212"
                        },
                        {
                          "String": "JTP 74057"
                        },
                        {
                          "String": "JTP-74057"
                        },
                        {
                          "String": "JTP74057"
                        },
                        {
                          "String": "trametinib"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Depositor-Supplied Synonyms",
                "Description": "Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.",
                "DisplayControls": {
                  "ListType": "Columns",
                  "MoveToTop": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Trametinib"
                        },
                        {
                          "String": "871700-17-3"
                        },
                        {
                          "String": "GSK1120212"
                        },
                        {
                          "String": "Mekinist"
                        },
                        {
                          "String": "GSK-1120212"
                        },
                        {
                          "String": "JTP 74057"
                        },
                        {
                          "String": "JTP-74057"
                        },
                        {
                          "String": "GSK 1120212"
                        },
                        {
                          "String": "Trametinib (GSK1120212)"
                        },
                        {
                          "String": "N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide"
                        },
                        {
                          "String": "UNII-33E86K87QN"
                        },
                        {
                          "String": "GSK212"
                        },
                        {
                          "String": "TMT212"
                        },
                        {
                          "String": "CHEBI:75998"
                        },
                        {
                          "String": "TMT-212"
                        },
                        {
                          "String": "33E86K87QN"
                        },
                        {
                          "String": "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide"
                        },
                        {
                          "String": "N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide"
                        },
                        {
                          "String": "N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide"
                        },
                        {
                          "String": "Trametinib [USAN:INN]"
                        },
                        {
                          "String": "trametinibum"
                        },
                        {
                          "String": "JTP74057"
                        },
                        {
                          "String": "N-(3-(3-Cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)acetamide"
                        },
                        {
                          "String": "N-(3-{3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydropyrido(4,3-d)pyrimidin-1(2H)-yl}phenyl)acetamide"
                        },
                        {
                          "String": "QOM"
                        },
                        {
                          "String": "Trametinib (USAN)"
                        },
                        {
                          "String": "Trametinib (GSK1120212JTP 74057)"
                        },
                        {
                          "String": "SCHEMBL170938"
                        },
                        {
                          "String": "C26H23FIN5O4"
                        },
                        {
                          "String": "GTPL6495"
                        },
                        {
                          "String": "GSK1120212 (Trametinib)"
                        },
                        {
                          "String": "CHEMBL2103875"
                        },
                        {
                          "String": "EX-A022"
                        },
                        {
                          "String": "BCPP000218"
                        },
                        {
                          "String": "DTXSID901007381"
                        },
                        {
                          "String": "HMS3295I05"
                        },
                        {
                          "String": "HMS3656J11"
                        },
                        {
                          "String": "BCP02307"
                        },
                        {
                          "String": "BDBM50531540"
                        },
                        {
                          "String": "MFCD17215075"
                        },
                        {
                          "String": "NSC758246"
                        },
                        {
                          "String": "NSC800956"
                        },
                        {
                          "String": "s2673"
                        },
                        {
                          "String": "ZINC43100709"
                        },
                        {
                          "String": "AKOS015850628"
                        },
                        {
                          "String": "AM90271"
                        },
                        {
                          "String": "CCG-264976"
                        },
                        {
                          "String": "CS-0060"
                        },
                        {
                          "String": "DB08911"
                        },
                        {
                          "String": "EX-5957"
                        },
                        {
                          "String": "NSC-758246"
                        },
                        {
                          "String": "NSC-800956"
                        },
                        {
                          "String": "SB16553"
                        },
                        {
                          "String": "NCGC00263180-01"
                        },
                        {
                          "String": "NCGC00263180-07"
                        },
                        {
                          "String": "NCGC00263180-14"
                        },
                        {
                          "String": "AC-25891"
                        },
                        {
                          "String": "AS-19382"
                        },
                        {
                          "String": "HY-10999"
                        },
                        {
                          "String": "N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6,8-dimethyl-2,4,7-trioxo-pyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide"
                        },
                        {
                          "String": "FT-0688438"
                        },
                        {
                          "String": "SW218089-2"
                        },
                        {
                          "String": "X7454"
                        },
                        {
                          "String": "A25168"
                        },
                        {
                          "String": "D10175"
                        },
                        {
                          "String": "GSK1120212 - JTP-74057"
                        },
                        {
                          "String": "GSK1120212,JTP-74057, GSK212"
                        },
                        {
                          "String": "SR-01000941589"
                        },
                        {
                          "String": "A1-01871"
                        },
                        {
                          "String": "J-523325"
                        },
                        {
                          "String": "Q7833138"
                        },
                        {
                          "String": "SR-01000941589-1"
                        },
                        {
                          "String": "BRD-K12343256-001-01-4"
                        },
                        {
                          "String": "Acetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8- dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-"
                        },
                        {
                          "String": "Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-"
                        },
                        {
                          "String": "N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide"
                        },
                        {
                          "String": "N-[3-[3-Cyclopropyl-5-[(2-Fluoro-4-Iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2h)-yl]phe nyl]acetamide"
                        },
                        {
                          "String": "N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamide"
                        },
                        {
                          "String": "N-{3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}ethanimidic acid"
                        },
                        {
                          "String": "N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide"
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Removed Synonyms",
                "Description": "Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.",
                "DisplayControls": {
                  "HideThisSection": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Trametinib [USAN]"
                        },
                        {
                          "String": "cc-37"
                        },
                        {
                          "String": "D04XVN"
                        },
                        {
                          "String": "D0F5RQ"
                        },
                        {
                          "String": "Trametinib (MEK inhibitor)"
                        },
                        {
                          "String": "QCR-39"
                        },
                        {
                          "String": "TRAMETINIB DIMETHYL SULFOXIDE"
                        },
                        {
                          "String": "GSK1120212B"
                        },
                        {
                          "String": "LIRYPHYGHXZJBZ-UHFFFAOYSA-N"
                        },
                        {
                          "String": "AOB87707"
                        },
                        {
                          "String": "ABP000312"
                        },
                        {
                          "String": "AN-539"
                        },
                        {
                          "String": "RW4149"
                        },
                        {
                          "String": "ACN-041327"
                        },
                        {
                          "String": "RL05418"
                        },
                        {
                          "String": "CID11707110"
                        },
                        {
                          "String": "4CA-0583"
                        },
                        {
                          "String": "AK174783"
                        },
                        {
                          "String": "BC638742"
                        },
                        {
                          "String": "CID 11707110"
                        },
                        {
                          "String": "SC-85458"
                        },
                        {
                          "String": "AB0008115"
                        },
                        {
                          "String": "A3018"
                        },
                        {
                          "String": "NS00040692"
                        },
                        {
                          "String": "KS-00000002"
                        },
                        {
                          "String": "A11029"
                        },
                        {
                          "String": "S-7800"
                        },
                        {
                          "String": "GSK-1120212/GSK1120212/"
                        },
                        {
                          "String": "C560077"
                        },
                        {
                          "String": "N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amin"
                        },
                        {
                          "String": "Trametinib, 98%, a MEK1/2 inhibitor - 10MG 10mg"
                        },
                        {
                          "String": "JTP-74057, 871700-17-3"
                        },
                        {
                          "String": "1187431-43-1"
                        },
                        {
                          "String": "(2S)-1-[(2S)-4-methyl-2-[[(2S)-5-oxo-1-phenylmethoxycarbonylpyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylic acid"
                        },
                        {
                          "String": "87171-07-1"
                        },
                        {
                          "String": "N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamide"
                        },
                        {
                          "String": "n-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyr"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Create Date",
            "Description": "Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.",
            "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/record-dates",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "DateISO8601": [
                    "2006-10-26"
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Modify Date",
            "Description": "Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.",
            "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/record-dates",
            "DisplayControls": {
              "HideThisSection": true,
              "MoveToTop": true
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "DateISO8601": [
                    "2022-10-01"
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical and Physical Properties",
        "Description": "Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.",
        "Section": [
          {
            "TOCHeading": "Computed Properties",
            "Description": "Properties of this compound computed from its molecular formula and structure.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "Subsections",
                "NumberOfColumns": 3,
                "ColumnHeadings": [
                  "Property Name",
                  "Property Value",
                  "Reference"
                ],
                "ColumnContents": [
                  "Name",
                  "Value",
                  "Reference"
                ]
              }
            },
            "Section": [
              {
                "TOCHeading": "Molecular Weight",
                "Description": "Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).",
                "URL": "https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en",
                "DisplayControls": {
                  "MoveToTop": true
                },
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem 2.1 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "615.4"
                        }
                      ],
                      "Unit": "g/mol"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "XLogP3",
                "Description": "XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.",
                "URL": "https://pubmed.ncbi.nlm.nih.gov/17985865/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Name": "XLogP3-AA",
                    "Reference": [
                      "Computed by XLogP3 3.0 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        3.4
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hydrogen Bond Donor Count",
                "Description": "The number of hydrogen bond donors in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        2
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hydrogen Bond Acceptor Count",
                "Description": "The number of hydrogen bond acceptors in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        6
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Rotatable Bond Count",
                "Description": "A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        5
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Exact Mass",
                "Description": "The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem 2.1 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "615.07788"
                        }
                      ],
                      "Unit": "g/mol"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Monoisotopic Mass",
                "Description": "The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem 2.1 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "615.07788"
                        }
                      ],
                      "Unit": "g/mol"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Topological Polar Surface Area",
                "Description": "The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.",
                "URL": "https://pubmed.ncbi.nlm.nih.gov/11020286/",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        102
                      ],
                      "Unit": "â«Â²"
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Heavy Atom Count",
                "Description": "The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        37
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Formal Charge",
                "Description": "Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Complexity",
                "Description": "The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.",
                "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/glossary$complexity",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by Cactvs 3.4.8.18 (PubChem release 2021.05.07)"
                    ],
                    "Value": {
                      "Number": [
                        1090
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Isotope Atom Count",
                "Description": "Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Defined Atom Stereocenter Count",
                "Description": "An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The \"defined atom stereocenter count\" is the number of atom stereocenters whose configurations are specifically defined.  ",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Undefined Atom Stereocenter Count",
                "Description": "The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the \"defined atom stereocenter count\" above.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Defined Bond Stereocenter Count",
                "Description": "A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The \"defined bond stereocenter count\" is the number of bond stereocenters whose configurations are specifically defined.  ",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Undefined Bond Stereocenter Count",
                "Description": "The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the \"defined bond stereocenter count\" above.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        0
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Covalently-Bonded Unit Count",
                "Description": "A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The \"covalently-bonded unit count\" property is the number of such units in this compound compound.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem"
                    ],
                    "Value": {
                      "Number": [
                        1
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Compound Is Canonicalized",
                "Description": "Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process.",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Reference": [
                      "Computed by PubChem (release 2021.05.07)"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Yes"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Experimental Properties",
            "Description": "Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.",
            "Section": [
              {
                "TOCHeading": "Melting Point",
                "Description": "This section provides the melting point and/or freezing point. The melting point is the temperature at which a substance changes state from solid to liquid at atmospheric pressure. When considered as the temperature of the reverse change (from liquid to solid), it is referred to as the freezing point.",
                "URL": "https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.01%3A_Melting_Point",
                "Information": [
                  {
                    "ReferenceNumber": 7,
                    "Reference": [
                      "MSDS"
                    ],
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "293-303"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Related Records",
        "Description": "Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.",
        "Section": [
          {
            "TOCHeading": "Related Compounds with Annotation",
            "Description": "Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the \"Related Compounds\" section below this section.  The \"Related Compounds\" include the parent, components, mixtures, and salt forms of this compound record as well as the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.",
            "URL": "https://doi.org/10.1186/s13321-016-0163-1",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Related Compounds",
            "Description": "Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the \"similar compounds\" and \"similar conformers\", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.",
            "URL": "https://doi.org/10.1186/s13321-016-0163-1",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 1
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "Same Connectivity Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound_sameconnectivity_pulldown&from_uid=11707110",
                "Value": {
                  "Number": [
                    5
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Same Parent, Connectivity Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound_parent_connectivity_pulldown&from_uid=11707110",
                "Value": {
                  "Number": [
                    22
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Same Parent, Exact Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound_parent_pulldown&from_uid=11707110",
                "Value": {
                  "Number": [
                    18
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Mixtures, Components, and Neutralized Forms Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound_mixture&from_uid=11707110",
                "Value": {
                  "Number": [
                    44
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Similar Compounds Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound&from_uid=11707110",
                "Value": {
                  "Number": [
                    359
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Similar Conformers Count",
                "URL": "https://www.ncbi.nlm.nih.gov/pccompound?cmd=Link&LinkName=pccompound_pccompound_3d&from_uid=11707110",
                "Value": {
                  "Number": [
                    154
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Substances",
            "Description": "Substance records associated with this compound.  In PubChem, the term \"substance\" refers to depositor-provided data for a chemical..",
            "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/substances",
            "Section": [
              {
                "TOCHeading": "Related Substances",
                "Description": "Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 1
                },
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Name": "All Count",
                    "URL": "https://www.ncbi.nlm.nih.gov/pcsubstance/?term=11707110[CompoundID]",
                    "Value": {
                      "Number": [
                        292
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 38,
                    "Name": "Same Count",
                    "URL": "https://www.ncbi.nlm.nih.gov/pcsubstance/?term=11707110[StandardizedCID]",
                    "Value": {
                      "Number": [
                        159
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 38,
                    "Name": "Mixture Count",
                    "URL": "https://www.ncbi.nlm.nih.gov/pcsubstance/?term=11707110[ComponentCID]",
                    "Value": {
                      "Number": [
                        133
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Substances by Category",
                "Description": "Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).",
                "Information": [
                  {
                    "ReferenceNumber": 38,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Chemical Vendors"
                        },
                        {
                          "String": "Curation Efforts"
                        },
                        {
                          "String": "Governmental Organizations"
                        },
                        {
                          "String": "Journal Publishers"
                        },
                        {
                          "String": "Legacy Depositors"
                        },
                        {
                          "String": "NIH Initiatives"
                        },
                        {
                          "String": "Research and Development"
                        },
                        {
                          "String": "Subscription Services"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "Entrez Crosslinks",
            "Description": "Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 1
            },
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "PubMed Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Number": [
                    16
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Protein Structures Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Number": [
                    3
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Taxonomy Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Number": [
                    2
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "OMIM Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Number": [
                    9
                  ]
                }
              },
              {
                "ReferenceNumber": 38,
                "Name": "Gene Count",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Number": [
                    31
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NCBI LinkOut",
            "Description": "NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.",
            "URL": "https://www.ncbi.nlm.nih.gov/projects/linkout/",
            "Information": [
              {
                "ReferenceNumber": 61,
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Chemical Vendors",
        "Description": "A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  ",
        "Information": [
          {
            "ReferenceNumber": 38,
            "Value": {
              "Boolean": [
                true
              ]
            }
          }
        ]
      },
      {
        "TOCHeading": "Drug and Medication Information",
        "Description": "This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.",
        "Section": [
          {
            "TOCHeading": "Drug Indication",
            "Description": "A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.",
            "DisplayControls": {
              "ShowAtMost": 3
            },
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test [FDA].  In May 2018, it was approved for use with [DB08912] for the treatment of treat anaplastic thyroid cancer caused by an abnormal BRAF V600E gene.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 7,
                "URL": "http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB08911.pdf?1372202916",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "FDA Label"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Drug Indication",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "MelanomaTrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation (see sections 4.4 and 5.1).Trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior BRAF inhibitor therapy (see section 5.1).Adjuvant treatment of melanomaTrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation, following complete resection.Non-small cell lung cancer (NSCLC)Trametinib in combination with dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.Â ",
                      "Markup": [
                        {
                          "Start": 57,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        },
                        {
                          "Start": 211,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 418,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        },
                        {
                          "Start": 601,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 632,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 28,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Drug: Trametinib",
                      "Markup": [
                        {
                          "Start": 6,
                          "Length": 10,
                          "URL": "https://www.cancer.gov/about-cancer/treatment/drugs/trametinib"
                        }
                      ]
                    },
                    {
                      "String": "US Brand Name(s): Mekinist",
                      "Markup": [
                        {
                          "Start": 18,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Mekinist",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    },
                    {
                      "String": "FDA Approval: Yes"
                    },
                    {
                      "String": "Trametinib dimethyl sulfoxide is approved to be used alone or with dabrafenib to treat patients whose cancer has a certain mutation in the BRAF gene, including:",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib%20dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        },
                        {
                          "Start": 67,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "â¢ Anaplastic thyroid cancer that is locally advanced or has spread to other parts of the body and cannot be treated with local therapy. It is used with dabrafenib.",
                      "Markup": [
                        {
                          "Start": 152,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "â¢ Melanoma. It is used:"
                    },
                    {
                      "String": "â¢ With dabrafenib in patients who have had surgery to remove cancer that has spread to the lymph nodes.",
                      "Markup": [
                        {
                          "Start": 7,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "â¢ Alone or with dabrafenib in patients whose cancer cannot be removed by surgery or has spread to other parts of the body.",
                      "Markup": [
                        {
                          "Start": 16,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "â¢ Non-small cell lung cancer that has metastasized. It is used with dabrafenib.",
                      "Markup": [
                        {
                          "Start": 68,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "â¢ Solid tumors. It is used with dabrafenib in adults and children aged 6 years and older whose tumors cannot be removed by surgery or have spread to other parts of the body and have gotten worse after other treatment and cannot be treated with other therapies.&#185;",
                      "Markup": [
                        {
                          "Start": 32,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-44462760"
                        }
                      ]
                    },
                    {
                      "String": "&#185;This use is approved under FDA&#8217;s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that trametinib dimethyl sulfoxide provides a clinical benefit in these patients. Trametinib dimethyl sulfoxide is also being studied in the treatment of other types of cancer.",
                      "Markup": [
                        {
                          "Start": 142,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib%20dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        },
                        {
                          "Start": 219,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib%20dimethyl%20sulfoxide",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "LiverTox Summary",
            "Description": "Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.",
            "URL": "https://www.ncbi.nlm.nih.gov/books/NBK547852/",
            "Information": [
              {
                "ReferenceNumber": 25,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a dual-kinase inhibitor that is used in the treatment of advanced malignant melanoma, usually in combination with darbafenib. Trametinib therapy is associated with transient elevations in serum aminotransferase and alkaline phosphatase levels during therapy, but has yet to be linked cases of clinically apparent acute liver injury.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 140,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Classes",
            "Description": "Drug classes of this compound, based on its therapeutic uses and/or structure.  The data presented in this section is from LiverTox.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/15404",
            "Information": [
              {
                "ReferenceNumber": 25,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Antineoplastic Agents"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug Effects during Lactation",
            "Description": "Summary of drug effects during lactation, from LactMed.",
            "URL": "https://www.ncbi.nlm.nih.gov/books/NBK501922/",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              }
            },
            "Information": [
              {
                "ReferenceNumber": 8,
                "Name": "Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "No information is available on the clinical use of trametinib during breastfeeding. Because trametinib is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 3.9 to 4.8 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during trametinib therapy and for 4 months after the last dose.",
                      "Markup": [
                        {
                          "Start": 51,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 92,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 327,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 8,
                "Name": "PubMed",
                "URL": "https://www.ncbi.nlm.nih.gov/pubmed/29999927",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "29999927"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 8,
                "Name": "NCBI Books",
                "URL": "https://www.ncbi.nlm.nih.gov/books/NBK500868/",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NBK500868"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Orange Book",
            "Description": "The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
            "Information": [
              {
                "ReferenceNumber": 20,
                "Value": {
                  "ExternalTableName": "fdaorangebook",
                  "ExternalTableNumRows": 1
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA National Drug Code Directory",
            "Description": "The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
            "Information": [
              {
                "ReferenceNumber": 26,
                "Value": {
                  "ExternalTableName": "fdandc"
                }
              }
            ]
          },
          {
            "TOCHeading": "Clinical Trials",
            "Description": "Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.",
            "Section": [
              {
                "TOCHeading": "ClinicalTrials.gov",
                "Description": "Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.",
                "URL": "http://clinicaltrials.gov/",
                "Information": [
                  {
                    "ReferenceNumber": 4,
                    "Name": "ClinicalTrials.gov",
                    "Value": {
                      "ExternalTableName": "clinicaltrials",
                      "ExternalTableNumRows": 197
                    }
                  }
                ]
              },
              {
                "TOCHeading": "EU Clinical Trials Register",
                "Description": "Brief clinical trials summary from the EU Clinical Trials Register.",
                "URL": "https://www.clinicaltrialsregister.eu/",
                "Information": [
                  {
                    "ReferenceNumber": 10,
                    "Name": "EU Clinical Trials Register",
                    "Value": {
                      "ExternalTableName": "clinicaltrials_eu",
                      "ExternalTableNumRows": 49
                    }
                  }
                ]
              },
              {
                "TOCHeading": "NIPH Clinical Trials Search of Japan",
                "Description": "Brief clinical trials summary from the NIPH Clinical Trials Search of Japan, which allows one to cross-search four national clinical research information registries in Japan: the Japan Registry of Clinical Trials (JRCT), the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials (JMACCT).",
                "URL": "https://rctportal.niph.go.jp/en/",
                "Information": [
                  {
                    "ReferenceNumber": 30,
                    "Name": "NIPH Clinical Trials Search of Japan",
                    "Value": {
                      "ExternalTableName": "clinicaltrials_jp",
                      "ExternalTableNumRows": 2
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "EMA Drug Information",
            "Description": "Drug information from the European Medicines Agency (EMA).",
            "URL": "https://www.ema.europa.eu/en",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 2
            },
            "Information": [
              {
                "ReferenceNumber": 13,
                "Name": "Medicine",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Mekinist"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Therapeutic area",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Melanoma"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Active Substance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "trametinib"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "INN/Common name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "trametinib"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Pharmacotherapeutic Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Antineoplastic agents"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Status",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "This medicine is authorized for use in the European Union"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Company",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Novartis Europharm Limited"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 13,
                "Name": "Market Date",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "2014-06-30"
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Pharmacology and Biochemistry",
        "Description": "Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.",
        "Section": [
          {
            "TOCHeading": "Pharmacodynamics",
            "Description": "Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.",
            "URL": "https://www.ncbi.nlm.nih.gov/books/NBK507791/",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is an anticancer agent which causes apoptosis (or programmed cell death) and inhibits cell proliferation, which are both important in the treatment of malignancies.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "MeSH Pharmacological Classification",
            "Description": "Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.",
            "URL": "https://meshb.nlm.nih.gov/record/ui?ui=D020228",
            "Information": [
              {
                "ReferenceNumber": 58,
                "Name": "Antineoplastic Agents",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)",
                      "Markup": [
                        {
                          "Start": 72,
                          "Length": 49,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68000970"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 59,
                "Name": "Protein Kinase Inhibitors",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)",
                      "Markup": [
                        {
                          "Start": 42,
                          "Length": 53,
                          "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68047428"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Pharmacological Classification",
            "Description": "Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.",
            "URL": "https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              }
            },
            "Information": [
              {
                "ReferenceNumber": 23,
                "Name": "FDA UNII",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "33E86K87QN"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 23,
                "Name": "Active Moiety",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "TRAMETINIB"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 23,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Established Pharmacologic Class [EPC] - Kinase Inhibitor"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 23,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Mechanisms of Action [MoA] - Protein Kinase Inhibitors"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 23,
                "Name": "FDA Pharmacology Summary",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a Kinase Inhibitor. The mechanism of action of trametinib is as a Protein Kinase Inhibitor.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 61,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 26,
                "Name": "Non-Proprietary Name",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "TRAMETINIB"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 26,
                "Name": "Pharmacological Classes",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Protein Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ATC Code",
            "Description": "The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.",
            "URL": "https://www.whocc.no/atc/structure_and_principles/",
            "Information": [
              {
                "ReferenceNumber": 13,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "L01EE01"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 36,
                "Name": "ATC Code",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "L - Antineoplastic and immunomodulating agents",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 1,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=L"
                        }
                      ]
                    },
                    {
                      "String": "L01 - Antineoplastic agents",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 3,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=L01"
                        }
                      ]
                    },
                    {
                      "String": "L01E - Protein kinase inhibitors",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 4,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=L01E"
                        }
                      ]
                    },
                    {
                      "String": "L01EE - Mitogen-activated protein kinase (mek) inhibitors",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 5,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=L01EE"
                        }
                      ]
                    },
                    {
                      "String": "L01EE01 - Trametinib",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.whocc.no/atc_ddd_index/?code=L01EE01"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Absorption, Distribution and Excretion",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Name": "Absorption",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is readily absorbed. When an oral administration of trametinib was given to patients with BRAF V600 mutation-positive melanoma, peak plasma concentration occurred 1.5 hours post-dose (Tmax). A single 2 mg oral dose has a bioavailability of 72%. When a dose of 2mg/day is given, the peak plasma concentration (Cmax) is 22.2 ng/mL.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 63,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 7,
                "Name": "Route of Elimination",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "80% of the dose is excreted in the feces. <20% of the dose is excreted in the urine with <0.1% of the excreted dose in the form of the parent compound."
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 7,
                "Name": "Volume of Distribution",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Apparent volume of distribution (Vd/F) = 214 L"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 7,
                "Name": "Clearance",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Apparent clearance = 4.9 L/h"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Metabolism/Metabolites",
            "Description": "Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is metabolized predominantly via deacetylation alone or with mono-oxygenation or in combination with glucuronidation biotransformation pathways in vitro. Deacetylation is likely mediated by hydrolytic enzymes, such as carboxyl-esterases or amidases. The cytochrome P450 enzyme system is not involved with the metabolism of trametinib. The predominant circulating component in the plasma is the parent drug.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 334,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Biological Half-Life",
            "Description": "The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Elimination half-life = 3.9-4.8 days."
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Mechanism of Action",
            "Description": "In medicine, the term \"mechanism of action\" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug's mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Trametinib is a reversible, allosteric inhibitor of mitogen-activated extracellular signal regulated kinase 1 _(MEK1)_ and _MEK2_ activation and of_ MEK1_ and _MEK2_ kinase activity. MEK proteins are upstream regulators of the extracellular signal-related kinase (ERK) pathway, which promotes cellular proliferation. Trametinib helps with melanoma with the BRAF V600E or V600K as the mutation results in the constitutive activation of the BRAF pathway which includes MEK1 and MEK2.",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 183,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        },
                        {
                          "Start": 317,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Use and Manufacturing",
        "Description": "This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.",
        "Section": [
          {
            "TOCHeading": "Uses",
            "Description": "Major uses of this chemical, including both consumer uses and industrial uses.",
            "Section": [
              {
                "TOCHeading": "Use Classification",
                "Description": "This section contains use classification/category information for this compound from various sources.",
                "Information": [
                  {
                    "ReferenceNumber": 13,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human drugs -> Mekinist -> EMA Drug Category",
                          "Markup": [
                            {
                              "Start": 15,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Mekinist",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 13,
                    "Name": "Use Classification",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Antineoplastic agents -> Human pharmacotherapeutic group"
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 20,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Safety and Hazards",
        "Description": "Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.",
        "Section": [
          {
            "TOCHeading": "Hazards Identification",
            "Description": "This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.",
            "URL": "https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf",
            "Section": [
              {
                "TOCHeading": "GHS Classification",
                "Description": "GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/",
                "DisplayControls": {
                  "CreateTable": {
                    "FromInformationIn": "ThisSection",
                    "NumberOfColumns": 2,
                    "ColumnContents": [
                      "Name",
                      "Value"
                    ]
                  },
                  "ShowAtMost": 1
                },
                "Information": [
                  {
                    "ReferenceNumber": 11,
                    "Name": "Pictogram(s)",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "          ",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 1,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg",
                              "Type": "Icon",
                              "Extra": "Irritant"
                            },
                            {
                              "Start": 1,
                              "Length": 1,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg",
                              "Type": "Icon",
                              "Extra": "Health Hazard"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 11,
                    "Name": "Signal",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Danger",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 11,
                    "Name": "GHS Hazard Statements",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]",
                          "Markup": [
                            {
                              "Start": 50,
                              "Length": 7,
                              "Type": "Color",
                              "Extra": "GHSWarning"
                            }
                          ]
                        },
                        {
                          "String": "H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]",
                          "Markup": [
                            {
                              "Start": 66,
                              "Length": 7,
                              "Type": "Color",
                              "Extra": "GHSWarning"
                            }
                          ]
                        },
                        {
                          "String": "H372 (100%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]",
                          "Markup": [
                            {
                              "Start": 77,
                              "Length": 6,
                              "Type": "Color",
                              "Extra": "GHSDanger"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 11,
                    "Name": "Precautionary Statement Codes",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "P203, P260, P261, P264, P270, P272, P280, P302+P352, P318, P319, P321, P333+P313, P362+P364, P405, and P501"
                        },
                        {
                          "String": "(The corresponding statement to each P-code can be found at the GHS Classification page.)",
                          "Markup": [
                            {
                              "Start": 64,
                              "Length": 18,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/#_prec"
                            }
                          ]
                        }
                      ]
                    }
                  },
                  {
                    "ReferenceNumber": 11,
                    "Name": "ECHA C&L Notifications Summary",
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.",
                          "Markup": [
                            {
                              "Start": 0,
                              "Length": 92,
                              "Type": "Italics"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hazard Classes and Categories",
                "Description": "The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/ghs/",
                "DisplayControls": {
                  "ShowAtMost": 2
                },
                "Information": [
                  {
                    "ReferenceNumber": 11,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Skin Sens. 1 (100%)"
                        },
                        {
                          "String": "Repr. 2 (100%)"
                        },
                        {
                          "String": "STOT RE 1 (100%)"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Toxicity",
        "Description": "Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.",
        "Section": [
          {
            "TOCHeading": "Toxicological Information",
            "Description": "This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.",
            "Section": [
              {
                "TOCHeading": "Toxicity Summary",
                "Description": "Summary of the toxicity of this compound, provided by the Hazardous Substances Data Bank (HSDB).",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/source/11933",
                "Information": [
                  {
                    "ReferenceNumber": 7,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "Most common adverse reactions (â¥20%) for trametinib include rash, diarrhea, and lymphedema.  The most common adverse reactions (â¥20%) for Tafinlar in combination with Trametinib are pyrexia, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, headache, arthralgia, night sweats, decreased appetite, constipation, and myalgia.  The following is a list of toxicities that may occur with the combination of Dabrafenib and Trametinib:  **New primary malignancies**: These may occur when Tafinlar is administered as a single agent or in combination with Trametinib. Monitor patients for new malignancies prior to initiation of therapy, while on therapy, and following discontinuation of TAFINLAR or the combination therapy. Tumor Promotion in BRAF Wild-Type Melanoma: Increased cell proliferation can occur with BRAF inhibitors.  **Hemorrhage**: Major hemorrhagic events can occur in patients receiving TAFINLAR in combination with trametinib. Monitor for signs and symptoms of bleeding.  **Venous Thromboembolism**: Deep vein thrombosis and pulmonary embolism can occur in patients receiving the drug combination.  **Cardiomyopathy**: Assess LVEF before treatment with TAFINLAR in combination with trametinib, after one month of treatment, then every 2 to 3 months thereafter.  **Ocular toxicities**: Perform an ophthalmologic evaluation for any visual disturbances.  **Serious Febrile Reactions**: Incidence and severity of pyrexia are increased with TAFINLAR in combination with trametinib.  **Serious Skin Toxicity**: Monitor for skin toxicities and for secondary infections. Discontinue for intolerable Grade 2, or Grade 3 or 4 rash not improving within 3 weeks despite the interruption of TAFINLAR.  **Hyperglycemia**: Monitor serum glucose levels in patients with pre-existing diabetes or hyperglycemia.  **Glucose-6-Phosphate Dehydrogenase Deficiency**: Closely monitor for hemolytic anemia.  **Embryofetal Toxicity**: Can cause fetal harm. Advise females of reproductive potential of potential risk to a fetus. TAFINLAR may render hormonal contraceptives less effective and an alternative method of contraception should be used.",
                          "Markup": [
                            {
                              "Start": 41,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 138,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Tafinlar",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 167,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 444,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 459,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 523,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Tafinlar",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 589,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 722,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 938,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 967,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 1205,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 1234,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 1488,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 1517,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 1730,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 1774,
                              "Length": 7,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/glucose",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5793"
                            },
                            {
                              "Start": 1849,
                              "Length": 19,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Glucose-6-Phosphate",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-5958"
                            },
                            {
                              "Start": 2055,
                              "Length": 8,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TAFINLAR",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            }
                          ]
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Hepatotoxicity",
                "Description": "This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.",
                "Information": [
                  {
                    "ReferenceNumber": 25,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "In large clinical trials, abnormalities in routine liver tests were common with serum aminotransferase elevations occurring in 39% to 60% and alkaline phosphatase in 24% to 67% of patients treated with trametinib. However, elevations in ALT above 5 times the ULN were uncommon, occurring in 0% to 5% of patients and generally resolving rapidly with temporary discontinuation or dose adjustment. In the prelicensure controlled trials of trametinib with or without dabrafenib, no cases of clinically apparent acute liver injury or hepatic failure were reported. There have yet to be published cases of clinically apparent hepatotoxicity attributed to trametinib. However, it has been used for a short time only.",
                          "Markup": [
                            {
                              "Start": 202,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 436,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            },
                            {
                              "Start": 463,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/dabrafenib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-44462760"
                            },
                            {
                              "Start": 649,
                              "Length": 10,
                              "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                              "Type": "PubChem Internal Link",
                              "Extra": "CID-11707110"
                            }
                          ]
                        },
                        {
                          "String": "Likelihood score: E* (unproven but suspected cause of clinically apparent liver injury)."
                        }
                      ]
                    }
                  }
                ]
              },
              {
                "TOCHeading": "Protein Binding",
                "Description": "In this section, \"protein binding\" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug's efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.",
                "Information": [
                  {
                    "ReferenceNumber": 7,
                    "Value": {
                      "StringWithMarkup": [
                        {
                          "String": "97.4% bound to human plasma proteins"
                        }
                      ]
                    }
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Associated Disorders and Diseases",
        "Description": "Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).",
        "DisplayControls": {
          "CreateTable": {
            "FromInformationIn": "Subsections",
            "NumberOfColumns": 2,
            "ColumnHeadings": [
              "Disease",
              "References"
            ],
            "ColumnContents": [
              "Name",
              "Value"
            ]
          }
        },
        "Information": [
          {
            "ReferenceNumber": 5,
            "Value": {
              "ExternalTableName": "ctd_chemical_disease"
            }
          }
        ]
      },
      {
        "TOCHeading": "Literature",
        "Description": "Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.",
        "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/literature",
        "Section": [
          {
            "TOCHeading": "Coronavirus Studies",
            "Description": "Literature references about coronavirus, aggregated from multiple sources, including PubMed, Protein Data Bank (PDB), DrugBank, and IUPHAR/BPS Guide to PHARMACOLOGY, Springer Nature, and ClinicalTrials.gov.  For clinical studies on coronavirus, see the Clinical Trials section.",
            "Information": [
              {
                "ReferenceNumber": 32,
                "Value": {
                  "ExternalTableName": "literature_coronavirus",
                  "ExternalTableNumRows": 8
                }
              }
            ]
          },
          {
            "TOCHeading": "NLM Curated PubMed Citations",
            "Description": "The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.",
            "URL": "https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6",
            "Information": [
              {
                "ReferenceNumber": 38,
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "Boolean": [
                    true
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Springer Nature References",
            "Description": "Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information.",
            "Information": [
              {
                "ReferenceNumber": 34,
                "Name": "Springer Nature References",
                "Value": {
                  "ExternalTableName": "springernature"
                }
              }
            ]
          },
          {
            "TOCHeading": "Thieme References",
            "Description": "Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.",
            "Information": [
              {
                "ReferenceNumber": 35,
                "Name": "Thieme References",
                "Value": {
                  "ExternalTableName": "ThiemeChemistry"
                }
              }
            ]
          },
          {
            "TOCHeading": "Depositor Provided PubMed Citations",
            "Description": "A list of PubMed records about this compound, provided by the depositors of all PubChem substance records that are standardized into this compound.",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "Depositor Provided PubMed Citations",
                "URL": "https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=11707110",
                "Value": {
                  "ExternalTableName": "collection=pubmed&pmidsrcs=xref",
                  "ExternalTableNumRows": 16
                }
              }
            ]
          },
          {
            "TOCHeading": "General References",
            "Description": "General references about this compound, collected from various sources.",
            "DisplayControls": {
              "ListType": "Numbered"
            },
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Salama AK, Kim KB: Trametinib (GSK1120212) in the treatment of melanoma. Expert Opin Pharmacother. 2013 Apr;14(5):619-27. doi: 10.1517/14656566.2013.770475. Epub 2013 Feb 23. [PMID:23432625]",
                      "Markup": [
                        {
                          "Start": 176,
                          "Length": 13,
                          "URL": "https://www.ncbi.nlm.nih.gov/pubmed/23432625"
                        },
                        {
                          "Start": 19,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/Trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 31,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/GSK1120212",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    },
                    {
                      "String": "Infante JR, Fecher LA, Falchook GS, Nallapareddy S, Gordon MS, Becerra C, DeMarini DJ, Cox DS, Xu Y, Morris SR, Peddareddigari VG, Le NT, Hart L, Bendell JC, Eckhardt G, Kurzrock R, Flaherty K, Burris HA 3rd, Messersmith WA: Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug;13(8):773-81. doi: 10.1016/S1470-2045(12)70270-X. Epub 2012 Jul 16. [PMID:22805291]",
                      "Markup": [
                        {
                          "Start": 449,
                          "Length": 13,
                          "URL": "https://www.ncbi.nlm.nih.gov/pubmed/22805291"
                        },
                        {
                          "Start": 298,
                          "Length": 3,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEK",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-6569"
                        },
                        {
                          "Start": 312,
                          "Length": 10,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/trametinib",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        }
                      ]
                    },
                    {
                      "String": "FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 118,
                          "URL": "https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm"
                        }
                      ]
                    },
                    {
                      "String": "Drugs@FDA: FDA Approved Drug Products",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 37,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 27,
                "URL": "http://dx.doi.org/10.1038/nchembio.2556",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Sonoshita et al. A whole-animal platform to advance a clinical kinase inhibitor into new disease space. Nature Chemical Biology, doi: 10.1038/nchembio.2556, published online 22 January 2018"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical Co-Occurrences in Literature",
            "Description": "Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalNeighbor"
                    },
                    {
                      "String": "Chemical"
                    },
                    {
                      "String": "ChemicalName_1"
                    },
                    {
                      "String": "ChemicalName_2"
                    },
                    {
                      "String": "SUMMARY_URL.cid"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "CID"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Gene Co-Occurrences in Literature",
            "Description": "Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalGeneSymbolNeighbor"
                    },
                    {
                      "String": "Gene/Protein/Enzyme"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "GeneSymbolName"
                    },
                    {
                      "String": "SUMMARY_URL.genesymbol"
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "GeneSymbol"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Disease Co-Occurrences in Literature",
            "Description": "Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.",
            "URL": "https://doi.org/10.3389/frma.2021.689059",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Name": "Co-Occurrence Panel",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "ChemicalDiseaseNeighbor"
                    },
                    {
                      "String": "Disease"
                    },
                    {
                      "String": "ChemicalName"
                    },
                    {
                      "String": "DiseaseName"
                    },
                    {
                      "String": "https://meshb.nlm.nih.gov/record/ui?ui="
                    },
                    {
                      "String": "CID"
                    },
                    {
                      "String": "MeSH"
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Patents",
        "Description": "Patent applications/documents that mention this compound.",
        "DisplayControls": {
          "ListType": "Columns"
        },
        "Information": [
          {
            "ReferenceNumber": 7,
            "Value": {
              "StringWithMarkup": [
                {
                  "String": "US8703781",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8703781"
                    }
                  ]
                },
                {
                  "String": "US8835443",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8835443"
                    }
                  ]
                },
                {
                  "String": "US9271941",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9271941"
                    }
                  ]
                },
                {
                  "String": "US9155706",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9155706"
                    }
                  ]
                },
                {
                  "String": "US7378423",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US7378423"
                    }
                  ]
                },
                {
                  "String": "US8580304",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8580304"
                    }
                  ]
                },
                {
                  "String": "US8952018",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US8952018"
                    }
                  ]
                },
                {
                  "String": "US9399021",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 9,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US9399021"
                    }
                  ]
                },
                {
                  "String": "US10869869",
                  "Markup": [
                    {
                      "Start": 0,
                      "Length": 10,
                      "URL": "https://pubchem.ncbi.nlm.nih.gov/patent/US10869869"
                    }
                  ]
                }
              ]
            }
          }
        ],
        "Section": [
          {
            "TOCHeading": "Depositor-Supplied Patent Identifiers",
            "Description": "Patent identifiers provided by data depositors, along with information on those patents.",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "ExternalTableName": "patent"
                }
              },
              {
                "ReferenceNumber": 38,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Link to all deposited patent identifiers",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 40,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/11707110/xrefs/PatentID/TXT"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "WIPO PATENTSCOPE",
            "Description": "Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system.",
            "URL": "https://www.wipo.int/patentscope/en/",
            "Information": [
              {
                "ReferenceNumber": 60,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Patents are available for this chemical structure:"
                    },
                    {
                      "String": "https://patentscope.wipo.int/search/en/result.jsf?inchikey=LIRYPHYGHXZJBZ-UHFFFAOYSA-N",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 86,
                          "URL": "https://patentscope.wipo.int/search/en/result.jsf?inchikey=LIRYPHYGHXZJBZ-UHFFFAOYSA-N"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Orange Book Patents",
            "Description": "Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA).  The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.",
            "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
            "DisplayControls": {
              "CreateTable": {
                "FromInformationIn": "ThisSection",
                "NumberOfColumns": 2,
                "ColumnContents": [
                  "Name",
                  "Value"
                ]
              },
              "ShowAtMost": 3
            },
            "Information": [
              {
                "ReferenceNumber": 14,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=7378423.PN.&OS=PN/7378423&RS=PN/7378423",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "7378423"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 14,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "May 29, 2027"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 14,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 14,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8580304.PN.&OS=PN/8580304&RS=PN/8580304",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "8580304"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Jan 28, 2032"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 15,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 16,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8703781.PN.&OS=PN/8703781&RS=PN/8703781",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "8703781"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 16,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Oct 15, 2030"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 16,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 16,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 17,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8835443.PN.&OS=PN/8835443&RS=PN/8835443",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "8835443"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 17,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Jun 10, 2025"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 17,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 17,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 18,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=9155706.PN.&OS=PN/9155706&RS=PN/9155706",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "9155706"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 18,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Jan 28, 2032"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 18,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 18,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 19,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=9271941.PN.&OS=PN/9271941&RS=PN/9271941",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "9271941"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 19,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Jan 28, 2032"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 19,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 19,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 21,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=9399021.PN.&OS=PN/9399021&RS=PN/9399021",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "9399021"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 21,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Jan 28, 2032"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 21,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 21,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 22,
                "Name": "Patent",
                "URL": "http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10869869.PN.&OS=PN/10869869&RS=PN/10869869",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "10869869"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 22,
                "Name": "Expiration",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Aug 30, 2033"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 22,
                "Name": "Applicant",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "NOVARTIS"
                    }
                  ]
                }
              },
              {
                "ReferenceNumber": 22,
                "Name": "Drug Application",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "N204114 (Prescription Drug: MEKINIST. Ingredients: TRAMETINIB DIMETHYL SULFOXIDE)",
                      "Markup": [
                        {
                          "Start": 0,
                          "Length": 7,
                          "URL": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204114"
                        },
                        {
                          "Start": 28,
                          "Length": 8,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/MEKINIST",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-11707110"
                        },
                        {
                          "Start": 51,
                          "Length": 29,
                          "URL": "https://pubchem.ncbi.nlm.nih.gov/compound/TRAMETINIB%20DIMETHYL%20SULFOXIDE",
                          "Type": "PubChem Internal Link",
                          "Extra": "CID-50992434"
                        }
                      ]
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Biomolecular Interactions and Pathways",
        "Description": "This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.",
        "Section": [
          {
            "TOCHeading": "Protein Bound 3D Structures",
            "Description": "Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.",
            "Information": [
              {
                "ReferenceNumber": 33,
                "Value": {
                  "ExternalTableName": "pdb"
                }
              },
              {
                "ReferenceNumber": 38,
                "URL": "https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=11707110",
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "View 3 proteins in NCBI Structure"
                    }
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug-Gene Interactions",
            "Description": "Drug-gene interactions provided by the Drug Gene Interaction Database (DGIdb).",
            "URL": "https://www.dgidb.org/",
            "Information": [
              {
                "ReferenceNumber": 6,
                "Value": {
                  "ExternalTableName": "collection=dgidb&view=concise_cid"
                }
              }
            ]
          },
          {
            "TOCHeading": "Chemical-Gene Interactions",
            "Description": "Interactions between this chemical and genes.",
            "Section": [
              {
                "TOCHeading": "CTD Chemical-Gene Interactions",
                "Description": "Chemical-gene interactions provided by the Comparative Toxicogenomics Database (CTD).",
                "URL": "https://ctdbase.org/",
                "Information": [
                  {
                    "ReferenceNumber": 5,
                    "Value": {
                      "ExternalTableName": "ctdchemicalgene"
                    }
                  }
                ]
              }
            ]
          },
          {
            "TOCHeading": "DrugBank Interactions",
            "Description": "Interaction of this compound (as a drug) with macromolecules (e.g., targets, enzymes, transporters, and carriers). The information in this section is from DrugBank.",
            "URL": "https://pubchem.ncbi.nlm.nih.gov/source/DrugBank",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "ExternalTableName": "collection=drugbank&view=concise_cid"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug-Drug Interactions",
            "Description": "Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.",
            "URL": "https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know",
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "ExternalTableName": "drugbankddi"
                }
              }
            ]
          },
          {
            "TOCHeading": "Drug-Food Interactions",
            "Description": "Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.",
            "URL": "https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know",
            "DisplayControls": {
              "ListType": "Bulleted"
            },
            "Information": [
              {
                "ReferenceNumber": 7,
                "Value": {
                  "StringWithMarkup": [
                    {
                      "String": "Take separate from meals. Take at least one hour before or two hours after a meal."
                    }
                  ]
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Biological Test Results",
        "Description": "A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.",
        "URL": "https://pubchemdocs.ncbi.nlm.nih.gov/widgets",
        "Section": [
          {
            "TOCHeading": "BioAssay Results",
            "Description": "Bioactivity data for this compound, reported in PubChem BioAssay records.",
            "Information": [
              {
                "ReferenceNumber": 38,
                "Value": {
                  "ExternalTableName": "bioactivity"
                }
              }
            ]
          }
        ]
      },
      {
        "TOCHeading": "Classification",
        "Description": "A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.",
        "Section": [
          {
            "TOCHeading": "MeSH Tree",
            "Description": "The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.",
            "URL": "https://www.nlm.nih.gov/mesh",
            "Information": [
              {
                "ReferenceNumber": 40,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1",
                "Value": {
                  "Number": [
                    1
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NCI Thesaurus Tree",
            "Description": "NCI Thesaurus (NCIt) hierarchy",
            "URL": "https://ncithesaurus.nci.nih.gov",
            "Information": [
              {
                "ReferenceNumber": 55,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112",
                "Value": {
                  "Number": [
                    112
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChEBI Ontology",
            "Description": "ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified.",
            "URL": "https://www.ebi.ac.uk/chebi/",
            "Information": [
              {
                "ReferenceNumber": 41,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2",
                "Value": {
                  "Number": [
                    2
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: ATC",
            "Description": "Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08303",
            "Information": [
              {
                "ReferenceNumber": 42,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16",
                "Value": {
                  "Number": [
                    16
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: Target-based Classification of Drugs",
            "Description": "Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).",
            "URL": "https://www.genome.jp/kegg-bin/get_htext?htext=br08310",
            "Information": [
              {
                "ReferenceNumber": 43,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22",
                "Value": {
                  "Number": [
                    22
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "KEGG: Drug Groups",
            "Description": "KEGG : Drug Groups tree",
            "Information": [
              {
                "ReferenceNumber": 51,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96",
                "Value": {
                  "Number": [
                    96
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "WHO ATC Classification System",
            "Description": "The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.",
            "URL": "https://www.who.int/tools/atc-ddd-toolkit/atc-classification",
            "Information": [
              {
                "ReferenceNumber": 46,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79",
                "Value": {
                  "Number": [
                    79
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Pharm Classes",
            "Description": "Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA \"Established Pharmacologic Class\" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.",
            "URL": "https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
            "Information": [
              {
                "ReferenceNumber": 45,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78",
                "Value": {
                  "Number": [
                    78
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChemIDplus",
            "Description": "Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).",
            "URL": "https://chem.nlm.nih.gov/chemidplus/",
            "Information": [
              {
                "ReferenceNumber": 48,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84",
                "Value": {
                  "Number": [
                    84
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "IUPHAR/BPS Guide to PHARMACOLOGY Target Classification",
            "Description": "Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.",
            "URL": "https://www.guidetopharmacology.org/",
            "Information": [
              {
                "ReferenceNumber": 50,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92",
                "Value": {
                  "Number": [
                    92
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "ChEMBL Target Tree",
            "Description": "Classification of this entity in the context of targets, provided by ChEMBL.",
            "URL": "https://www.ebi.ac.uk/chembl/",
            "Information": [
              {
                "ReferenceNumber": 49,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87",
                "Value": {
                  "Number": [
                    87
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "UN GHS Classification",
            "Description": "The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures.",
            "URL": "https://unece.org/about-ghs",
            "Information": [
              {
                "ReferenceNumber": 47,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83",
                "Value": {
                  "Number": [
                    83
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "NORMAN Suspect List Exchange Classification",
            "Description": "A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.",
            "URL": "https://www.norman-network.com/nds/SLE/",
            "Information": [
              {
                "ReferenceNumber": 52,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101",
                "Value": {
                  "Number": [
                    101
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "EPA DSSTox Classification",
            "Description": "Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. ",
            "URL": "https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database",
            "Information": [
              {
                "ReferenceNumber": 53,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105",
                "Value": {
                  "Number": [
                    105
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "FDA Drug Type and Pharmacologic Classification",
            "Description": "The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.",
            "Information": [
              {
                "ReferenceNumber": 56,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116",
                "Value": {
                  "Number": [
                    116
                  ]
                }
              }
            ]
          },
          {
            "TOCHeading": "PFAS and Fluorinated Organic Compounds in PubChem",
            "Description": "A classification tree to browse per- and polyfluoroalkyl substances (PFAS) and other fluorinated organic compounds in PubChem.",
            "Information": [
              {
                "ReferenceNumber": 57,
                "Name": "HID",
                "URL": "https://pubchem.ncbi.nlm.nih.gov/classification/#hid=120",
                "Value": {
                  "Number": [
                    120
                  ]
                }
              }
            ]
          }
        ]
      }
    ],
    "Reference": [
      {
        "ReferenceNumber": 1,
        "SourceName": "CAS Common Chemistry",
        "SourceID": "871700-17-3",
        "Name": "Trametinib",
        "Description": "CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.",
        "URL": "https://commonchemistry.cas.org/detail?cas_rn=871700-17-3",
        "LicenseNote": "The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.",
        "LicenseURL": "https://creativecommons.org/licenses/by-nc/4.0/",
        "ANID": 12953898
      },
      {
        "ReferenceNumber": 3,
        "SourceName": "ChemIDplus",
        "SourceID": "0871700173",
        "Name": "Trametinib [USAN:INN]",
        "Description": "ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.",
        "URL": "https://chem.nlm.nih.gov/chemidplus/sid/0871700173",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true,
        "ANID": 1140426
      },
      {
        "ReferenceNumber": 7,
        "SourceName": "DrugBank",
        "SourceID": "DB08911",
        "Name": "Trametinib",
        "Description": "The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.",
        "URL": "https://www.drugbank.ca/drugs/DB08911",
        "LicenseNote": "Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)",
        "LicenseURL": "https://www.drugbank.ca/legal/terms_of_use",
        "ANID": 3624833
      },
      {
        "ReferenceNumber": 9,
        "SourceName": "EPA DSSTox",
        "SourceID": "DTXSID901007381",
        "Name": "N-{3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}ethanimidic acid",
        "Description": "DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.",
        "URL": "https://comptox.epa.gov/dashboard/DTXSID901007381",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources",
        "ANID": 17762695
      },
      {
        "ReferenceNumber": 12,
        "SourceName": "European Chemicals Agency (ECHA)",
        "SourceID": "629-899-3",
        "Name": "N-{3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}acetamide",
        "Description": "The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.",
        "URL": "https://echa.europa.eu/information-on-chemicals",
        "LicenseNote": "Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.",
        "LicenseURL": "https://echa.europa.eu/web/guest/legal-notice",
        "ANID": 15113154
      },
      {
        "ReferenceNumber": 2,
        "SourceName": "ChEBI",
        "SourceID": "CHEBI:OBO:11707110",
        "Name": "Trametinib",
        "Description": "Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on 'small' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term \"molecular entity\" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.",
        "URL": "http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75998",
        "ANID": 2455294
      },
      {
        "ReferenceNumber": 23,
        "SourceName": "FDA Pharm Classes",
        "SourceID": "33E86K87QN",
        "Name": "TRAMETINIB",
        "Description": "FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class",
        "URL": "https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 13206673
      },
      {
        "ReferenceNumber": 25,
        "SourceName": "LiverTox",
        "SourceID": "Trametinib",
        "Name": "Trametinib",
        "Description": "LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.",
        "URL": "https://www.ncbi.nlm.nih.gov/books/n/livertox/Trametinib/",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true,
        "ANID": 2262487
      },
      {
        "ReferenceNumber": 29,
        "SourceName": "NCI Thesaurus (NCIt)",
        "SourceID": "C77908::Compound",
        "Description": "NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.",
        "URL": "https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C77908",
        "LicenseNote": "Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.",
        "LicenseURL": "https://www.cancer.gov/policies/copyright-reuse",
        "ANID": 14394852
      },
      {
        "ReferenceNumber": 4,
        "SourceName": "ClinicalTrials.gov",
        "SourceID": "cid11707110",
        "Description": "ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.",
        "URL": "https://clinicaltrials.gov/",
        "LicenseNote": "The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.",
        "LicenseURL": "https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use",
        "ANID": 5186924
      },
      {
        "ReferenceNumber": 5,
        "SourceName": "Comparative Toxicogenomics Database (CTD)",
        "SourceID": "C560077::Compound",
        "Description": "CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.",
        "URL": "https://ctdbase.org/detail.go?type=chem&acc=C560077",
        "LicenseNote": "It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.",
        "LicenseURL": "http://ctdbase.org/about/legal.jsp",
        "ANID": 9022497
      },
      {
        "ReferenceNumber": 6,
        "SourceName": "Drug Gene Interaction database (DGIdb)",
        "SourceID": "TRAMETINIB",
        "Description": "The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.",
        "URL": "https://www.dgidb.org/drugs/TRAMETINIB",
        "LicenseNote": "The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.",
        "LicenseURL": "http://www.dgidb.org/downloads",
        "ANID": 8266297
      },
      {
        "ReferenceNumber": 27,
        "SourceName": "Nature Chemical Biology",
        "SourceID": "nchembio.2556-comp3",
        "Description": "Nature Chemical Biology is an international monthly journal that provides a high-visibility forum for the publication of top-tier original research and commentary for the chemical biology community. Chemical biology combines the scientific ideas and approaches of chemistry, biology and allied disciplines to understand and manipulate biological systems with molecular precision.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/350080691",
        "ANID": 8542044
      },
      {
        "ReferenceNumber": 13,
        "SourceName": "European Medicines Agency (EMA)",
        "SourceID": "EMEA/H/C/002643_1",
        "Name": "Mekinist (EMEA/H/C/002643)",
        "Description": "The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.",
        "URL": "https://www.ema.europa.eu/en/medicines/human/EPAR/mekinist",
        "LicenseNote": "Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices.",
        "LicenseURL": "https://www.ema.europa.eu/en/about-us/legal-notice",
        "ANID": 8855356
      },
      {
        "ReferenceNumber": 28,
        "SourceName": "NCI Cancer Drugs",
        "SourceID": "cd_173",
        "Name": "trametinib",
        "Description": "The collection of NCI Cancer Drugs has over 200 cancer drug information summaries from NCI. The summaries provide consumer-friendly information about cancer drugs and drug combinations.",
        "URL": "https://www.cancer.gov/about-cancer/treatment/drugs/trametinib",
        "LicenseURL": "https://www.cancer.gov/policies/copyright-reuse",
        "ANID": 761717
      },
      {
        "ReferenceNumber": 8,
        "SourceName": "Drugs and Lactation Database (LactMed)",
        "SourceID": "NBK500868",
        "Name": "Trametinib",
        "Description": "The LactMedÂ® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/",
        "URL": "https://www.ncbi.nlm.nih.gov/books/NBK500868/",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "ANID": 5123414
      },
      {
        "ReferenceNumber": 10,
        "SourceName": "EU Clinical Trials Register",
        "SourceID": "cid11707110",
        "Description": "The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.",
        "URL": "https://www.clinicaltrialsregister.eu/",
        "ANID": 6482979
      },
      {
        "ReferenceNumber": 11,
        "SourceName": "European Chemicals Agency (ECHA)",
        "SourceID": "162903",
        "Name": "N-{3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl}acetamide",
        "Description": "The information provided here is aggregated from the \"Notified classification and labelling\" from ECHA's C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database",
        "URL": "https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/162903",
        "LicenseNote": "Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.",
        "LicenseURL": "https://echa.europa.eu/web/guest/legal-notice",
        "ANID": 1900022
      },
      {
        "ReferenceNumber": 20,
        "SourceName": "FDA Orange Book",
        "SourceID": "org_11707110",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 3594868
      },
      {
        "ReferenceNumber": 36,
        "SourceName": "WHO Anatomical Therapeutic Chemical (ATC) Classification",
        "SourceID": "201",
        "Description": "The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.",
        "URL": "https://www.whocc.no/atc/",
        "LicenseNote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
        "LicenseURL": "https://www.whocc.no/copyright_disclaimer/",
        "ANID": 752462
      },
      {
        "ReferenceNumber": 14,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_7378423",
        "Name": "Patent:7378423",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 404415
      },
      {
        "ReferenceNumber": 15,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_8580304",
        "Name": "Patent:8580304",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 405734
      },
      {
        "ReferenceNumber": 16,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_8703781",
        "Name": "Patent:8703781",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 405920
      },
      {
        "ReferenceNumber": 17,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_8835443",
        "Name": "Patent:8835443",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 406097
      },
      {
        "ReferenceNumber": 18,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_9155706",
        "Name": "Patent:9155706",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 406485
      },
      {
        "ReferenceNumber": 19,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_9271941",
        "Name": "Patent:9271941",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 406622
      },
      {
        "ReferenceNumber": 21,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_9399021",
        "Name": "Patent:9399021",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 8512801
      },
      {
        "ReferenceNumber": 22,
        "SourceName": "FDA Orange Book",
        "SourceID": "orgp_10869869",
        "Name": "Patent:10869869",
        "Description": "The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 13726946
      },
      {
        "ReferenceNumber": 26,
        "SourceName": "National Drug Code (NDC) Directory",
        "SourceID": "n_TRAMETINIB",
        "Name": "TRAMETINIB",
        "Description": "The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA.",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 15088583
      },
      {
        "ReferenceNumber": 24,
        "SourceName": "FDA/SPL Indexing Data",
        "SourceID": "33E86K87QN",
        "Name": "33E86K87QN",
        "Description": "The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).",
        "URL": "https://www.fda.gov/ForIndustry/DataStandards/SubstanceRegistrationSystem-UniqueIngredientIdentifierUNII/",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking",
        "ANID": 5838561
      },
      {
        "ReferenceNumber": 30,
        "SourceName": "NIPH Clinical Trials Search of Japan",
        "SourceID": "cid11707110",
        "Description": "NIPH Clinical Trials Search of Japan allows one to search clinical research (trials) from the registries of three institutions; the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials.",
        "URL": "https://rctportal.niph.go.jp/en/",
        "ANID": 9121456
      },
      {
        "ReferenceNumber": 31,
        "SourceName": "NLM RxNorm Terminology",
        "SourceID": "1425099",
        "Description": "RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.",
        "URL": "https://rxnav.nlm.nih.gov/id/rxnorm/1425099",
        "LicenseNote": "The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.",
        "LicenseURL": "https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html",
        "ANID": 15098569
      },
      {
        "ReferenceNumber": 32,
        "SourceName": "PubChem",
        "SourceID": "covid19_l_874",
        "URL": "https://pubchem.ncbi.nlm.nih.gov",
        "ANID": 9033746
      },
      {
        "ReferenceNumber": 33,
        "SourceName": "RCSB Protein Data Bank (RCSB PDB)",
        "SourceID": "11707110",
        "Description": "The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.",
        "URL": "https://www.rcsb.org/",
        "LicenseNote": "Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.",
        "LicenseURL": "https://www.rcsb.org/pages/policies",
        "ANID": 13133228
      },
      {
        "ReferenceNumber": 34,
        "SourceName": "Springer Nature",
        "SourceID": "37061692-559179997",
        "Description": "Literature references related to scientific contents from Springer Nature journals and books. https://link.springer.com/",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/341740665",
        "ANID": 4369875
      },
      {
        "ReferenceNumber": 35,
        "SourceName": "Thieme Chemistry",
        "SourceID": "37061702-188600455",
        "Description": "Literature references related to scientific contents from Thieme journals and books. Read more: http://www.thieme-chemistry.com",
        "LicenseNote": "The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.",
        "LicenseURL": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
        "ANID": 5722047
      },
      {
        "ReferenceNumber": 37,
        "SourceName": "Wikidata",
        "SourceID": "Q7833138",
        "Name": "Trametinib",
        "Description": "Link to the compound information in Wikidata.",
        "URL": "https://www.wikidata.org/wiki/Q7833138",
        "LicenseNote": "CCZero",
        "LicenseURL": "https://creativecommons.org/publicdomain/zero/1.0/",
        "ANID": 16314518
      },
      {
        "ReferenceNumber": 38,
        "SourceName": "PubChem",
        "SourceID": "PubChem",
        "Description": "Data deposited in or computed by PubChem",
        "URL": "https://pubchem.ncbi.nlm.nih.gov"
      },
      {
        "ReferenceNumber": 39,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "67560077",
        "Name": "trametinib",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/67560077",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 40,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "DescTree",
        "Name": "MeSH Tree",
        "Description": "MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "http://www.nlm.nih.gov/mesh/meshhome.html",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 41,
        "SourceName": "ChEBI",
        "SourceID": "OBO",
        "Name": "ChEBI Ontology",
        "Description": "The ChEBI Ontology is a structured classification of the entities contained within ChEBI.",
        "URL": "http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology"
      },
      {
        "ReferenceNumber": 42,
        "SourceName": "KEGG",
        "SourceID": "br08303",
        "Name": "Anatomical Therapeutic Chemical (ATC) classification",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08303.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 43,
        "SourceName": "KEGG",
        "SourceID": "br08310",
        "Name": "Target-based classification of drugs",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08310.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 45,
        "SourceName": "FDA Pharm Classes",
        "SourceID": "FDA_pharm_tree",
        "Name": "FDA Pharmacological Classification",
        "Description": "FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.",
        "URL": "https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking"
      },
      {
        "ReferenceNumber": 46,
        "SourceName": "WHO Anatomical Therapeutic Chemical (ATC) Classification",
        "SourceID": "ATCTree",
        "Name": "ATC Code",
        "Description": "In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.",
        "URL": "https://www.whocc.no/atc_ddd_index/",
        "LicenseNote": "Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.",
        "LicenseURL": "https://www.whocc.no/copyright_disclaimer/"
      },
      {
        "ReferenceNumber": 47,
        "SourceName": "UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)",
        "SourceID": "UN_GHS_tree",
        "Name": "GHS Classification Tree",
        "Description": "The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures. It sets up criteria for the classification of chemicals for physical-chemical, health, and environmental hazards of chemical substances and mixtures and sets up standardized hazard information to facilitate global trade of chemicals.  Please note that obsolete codes are added in this classification for completeness purposes, as they are still in use. Any obsolete codes are annotated as such.",
        "URL": "http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html"
      },
      {
        "ReferenceNumber": 48,
        "SourceName": "ChemIDplus",
        "SourceID": "ChemIDplus_tree",
        "Name": "ChemIDplus Chemical Information Classification",
        "Description": "ChemIDplus is a TOXNET (TOXicology Data NETwork) databases that contain chemicals and drugs related information. It is managed by the Toxicology and Environmental Health Information Program (TEHIP) in the Division of Specialized Information Services (SIS) of the National Library of Medicine (NLM).",
        "URL": "https://chem.nlm.nih.gov/chemidplus/",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html",
        "IsToxnet": true
      },
      {
        "ReferenceNumber": 49,
        "SourceName": "ChEMBL",
        "SourceID": "Target Tree",
        "Name": "ChEMBL Protein Target Tree",
        "Description": "The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 31.",
        "URL": "https://www.ebi.ac.uk/chembl/g/#browse/targets",
        "LicenseNote": "Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).",
        "LicenseURL": "http://www.ebi.ac.uk/Information/termsofuse.html"
      },
      {
        "ReferenceNumber": 50,
        "SourceName": "IUPHAR/BPS Guide to PHARMACOLOGY",
        "SourceID": "Target Classification",
        "Name": "Guide to Pharmacology Target Classification",
        "Description": "An expert-driven guide to pharmacological targets and the substances that act on them",
        "URL": "https://www.guidetopharmacology.org/targets.jsp",
        "LicenseNote": "The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)",
        "LicenseURL": "https://www.guidetopharmacology.org/about.jsp#license"
      },
      {
        "ReferenceNumber": 51,
        "SourceName": "KEGG",
        "SourceID": "br08330",
        "Name": "Drug Groups",
        "Description": "KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.",
        "URL": "http://www.genome.jp/kegg-bin/get_htext?br08330.keg",
        "LicenseNote": "Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license",
        "LicenseURL": "https://www.kegg.jp/kegg/legal.html"
      },
      {
        "ReferenceNumber": 52,
        "SourceName": "NORMAN Suspect List Exchange",
        "SourceID": "norman_sle_tree",
        "Name": "NORMAN Suspect List Exchange Classification",
        "Description": "The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.<br>Update: 2022-09-11 10:13:01",
        "URL": "https://www.norman-network.com/nds/SLE/",
        "LicenseNote": "Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0",
        "LicenseURL": "https://creativecommons.org/licenses/by/4.0/"
      },
      {
        "ReferenceNumber": 53,
        "SourceName": "EPA DSSTox",
        "SourceID": "dsstoxlist_tree",
        "Name": "CompTox Chemicals Dashboard Chemical Lists",
        "Description": "This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.<br>Update: 08/10/22 11:22:34",
        "URL": "https://comptox.epa.gov/dashboard/chemical-lists/",
        "LicenseURL": "https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources"
      },
      {
        "ReferenceNumber": 55,
        "SourceName": "NCI Thesaurus (NCIt)",
        "SourceID": "NCIt",
        "Name": "NCI Thesaurus Tree",
        "Description": "The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.",
        "URL": "https://ncit.nci.nih.gov",
        "LicenseNote": "Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.",
        "LicenseURL": "https://www.cancer.gov/policies/copyright-reuse"
      },
      {
        "ReferenceNumber": 56,
        "SourceName": "National Drug Code (NDC) Directory",
        "SourceID": "fdandc_tree",
        "Name": "FDA Drug Type and Pharmacologic Classification",
        "Description": "The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.",
        "URL": "https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory",
        "LicenseNote": "Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.",
        "LicenseURL": "https://www.fda.gov/about-fda/about-website/website-policies#linking"
      },
      {
        "ReferenceNumber": 57,
        "SourceName": "PubChem",
        "SourceID": "pfas5_pubchem_tree",
        "Name": "PFAS and Fluorinated Compounds in PubChem",
        "Description": "A classification tree to browse per- and polyfluoroalkyl substances (PFAS) and other fluorinated compounds in PubChem. The 'OECD PFAS definition' node contains PubChem content matching the OECD PFAS definition of saturated CF2 (Report ENV/CBC/MONO(2021)25 from 9 July 2021). The 'Organofluorine compounds' node contains organofluorine compounds in PubChem as defined in the same report. The 'Other diverse fluorinated compounds' node helps explore a wide variety of other fluorinated compounds. The 'PFAS and fluorinated compound collections' node gathers several collections of PFAS and/or fluorinated compounds from various resources. <br>Update: 2022-09-12 14:04:56",
        "URL": "https://gitlab.lcsb.uni.lu/eci/pubchem-docs/-/raw/main/pfas-tree/PFAS_Tree.pdf?inline=false"
      },
      {
        "ReferenceNumber": 58,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68000970",
        "Name": "Antineoplastic Agents",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68000970",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 59,
        "SourceName": "Medical Subject Headings (MeSH)",
        "SourceID": "68047428",
        "Name": "Protein Kinase Inhibitors",
        "Description": "MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed.",
        "URL": "https://www.ncbi.nlm.nih.gov/mesh/68047428",
        "LicenseNote": "Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.",
        "LicenseURL": "https://www.nlm.nih.gov/copyright.html"
      },
      {
        "ReferenceNumber": 60,
        "SourceName": "PATENTSCOPE (WIPO)",
        "Name": "SID 390643768",
        "Description": "The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.",
        "URL": "https://pubchem.ncbi.nlm.nih.gov/substance/390643768"
      },
      {
        "ReferenceNumber": 61,
        "SourceName": "NCBI",
        "SourceID": "LinkOut",
        "Description": "LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.",
        "URL": "https://www.ncbi.nlm.nih.gov/projects/linkout"
      }
    ]
  }
}
